Cargando…
Rapid expansion of Treg cells protects from collateral colitis following a viral trigger
Foxp3(+) regulatory T (Treg) cells are essential for maintaining peripheral tolerance and preventing autoimmunity. While genetic factors may predispose for autoimmunity, additional environmental triggers, such as viral infections, are usually required to initiate the onset of disease. Here, we show...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090079/ https://www.ncbi.nlm.nih.gov/pubmed/32251280 http://dx.doi.org/10.1038/s41467-020-15309-6 |
_version_ | 1783509857341538304 |
---|---|
author | Schorer, Michelle Lambert, Katharina Rakebrandt, Nikolas Rost, Felix Kao, Kung-Chi Yermanos, Alexander Spörri, Roman Oderbolz, Josua Raeber, Miro E. Keller, Christian W. Lünemann, Jan D. Rogler, Gerhard Boyman, Onur Oxenius, Annette Joller, Nicole |
author_facet | Schorer, Michelle Lambert, Katharina Rakebrandt, Nikolas Rost, Felix Kao, Kung-Chi Yermanos, Alexander Spörri, Roman Oderbolz, Josua Raeber, Miro E. Keller, Christian W. Lünemann, Jan D. Rogler, Gerhard Boyman, Onur Oxenius, Annette Joller, Nicole |
author_sort | Schorer, Michelle |
collection | PubMed |
description | Foxp3(+) regulatory T (Treg) cells are essential for maintaining peripheral tolerance and preventing autoimmunity. While genetic factors may predispose for autoimmunity, additional environmental triggers, such as viral infections, are usually required to initiate the onset of disease. Here, we show that viral infection with LCMV results in type I IFN-dependent Treg cell loss that is rapidly compensated by the conversion and expansion of Vβ5(+) conventional T cells into iTreg cells. Using Vβ5-deficient mice, we show that these Vβ5(+) iTreg cells are dispensable for limiting anti-viral immunity. Rather, the delayed replenishment of Treg cells in Vβ5-deficient mice compromises suppression of microbiota-dependent activation of CD8(+) T cells, resulting in colitis. Importantly, recovery from clinical symptoms in IBD patients is marked by expansion of the corresponding Vβ2(+) Treg population in humans. Collectively, we provide a link between a viral trigger and an impaired Treg cell compartment resulting in the initiation of immune pathology. |
format | Online Article Text |
id | pubmed-7090079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70900792020-03-26 Rapid expansion of Treg cells protects from collateral colitis following a viral trigger Schorer, Michelle Lambert, Katharina Rakebrandt, Nikolas Rost, Felix Kao, Kung-Chi Yermanos, Alexander Spörri, Roman Oderbolz, Josua Raeber, Miro E. Keller, Christian W. Lünemann, Jan D. Rogler, Gerhard Boyman, Onur Oxenius, Annette Joller, Nicole Nat Commun Article Foxp3(+) regulatory T (Treg) cells are essential for maintaining peripheral tolerance and preventing autoimmunity. While genetic factors may predispose for autoimmunity, additional environmental triggers, such as viral infections, are usually required to initiate the onset of disease. Here, we show that viral infection with LCMV results in type I IFN-dependent Treg cell loss that is rapidly compensated by the conversion and expansion of Vβ5(+) conventional T cells into iTreg cells. Using Vβ5-deficient mice, we show that these Vβ5(+) iTreg cells are dispensable for limiting anti-viral immunity. Rather, the delayed replenishment of Treg cells in Vβ5-deficient mice compromises suppression of microbiota-dependent activation of CD8(+) T cells, resulting in colitis. Importantly, recovery from clinical symptoms in IBD patients is marked by expansion of the corresponding Vβ2(+) Treg population in humans. Collectively, we provide a link between a viral trigger and an impaired Treg cell compartment resulting in the initiation of immune pathology. Nature Publishing Group UK 2020-03-23 /pmc/articles/PMC7090079/ /pubmed/32251280 http://dx.doi.org/10.1038/s41467-020-15309-6 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Schorer, Michelle Lambert, Katharina Rakebrandt, Nikolas Rost, Felix Kao, Kung-Chi Yermanos, Alexander Spörri, Roman Oderbolz, Josua Raeber, Miro E. Keller, Christian W. Lünemann, Jan D. Rogler, Gerhard Boyman, Onur Oxenius, Annette Joller, Nicole Rapid expansion of Treg cells protects from collateral colitis following a viral trigger |
title | Rapid expansion of Treg cells protects from collateral colitis following a viral trigger |
title_full | Rapid expansion of Treg cells protects from collateral colitis following a viral trigger |
title_fullStr | Rapid expansion of Treg cells protects from collateral colitis following a viral trigger |
title_full_unstemmed | Rapid expansion of Treg cells protects from collateral colitis following a viral trigger |
title_short | Rapid expansion of Treg cells protects from collateral colitis following a viral trigger |
title_sort | rapid expansion of treg cells protects from collateral colitis following a viral trigger |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090079/ https://www.ncbi.nlm.nih.gov/pubmed/32251280 http://dx.doi.org/10.1038/s41467-020-15309-6 |
work_keys_str_mv | AT schorermichelle rapidexpansionoftregcellsprotectsfromcollateralcolitisfollowingaviraltrigger AT lambertkatharina rapidexpansionoftregcellsprotectsfromcollateralcolitisfollowingaviraltrigger AT rakebrandtnikolas rapidexpansionoftregcellsprotectsfromcollateralcolitisfollowingaviraltrigger AT rostfelix rapidexpansionoftregcellsprotectsfromcollateralcolitisfollowingaviraltrigger AT kaokungchi rapidexpansionoftregcellsprotectsfromcollateralcolitisfollowingaviraltrigger AT yermanosalexander rapidexpansionoftregcellsprotectsfromcollateralcolitisfollowingaviraltrigger AT sporriroman rapidexpansionoftregcellsprotectsfromcollateralcolitisfollowingaviraltrigger AT oderbolzjosua rapidexpansionoftregcellsprotectsfromcollateralcolitisfollowingaviraltrigger AT raebermiroe rapidexpansionoftregcellsprotectsfromcollateralcolitisfollowingaviraltrigger AT kellerchristianw rapidexpansionoftregcellsprotectsfromcollateralcolitisfollowingaviraltrigger AT lunemannjand rapidexpansionoftregcellsprotectsfromcollateralcolitisfollowingaviraltrigger AT roglergerhard rapidexpansionoftregcellsprotectsfromcollateralcolitisfollowingaviraltrigger AT boymanonur rapidexpansionoftregcellsprotectsfromcollateralcolitisfollowingaviraltrigger AT oxeniusannette rapidexpansionoftregcellsprotectsfromcollateralcolitisfollowingaviraltrigger AT jollernicole rapidexpansionoftregcellsprotectsfromcollateralcolitisfollowingaviraltrigger |